XLR-11 and UR-144 in Washington State and State of Alaska driving cases

Journal of Analytical Toxicology

Volumn 38, Issue 8, 2014, Pages 563-568

  Louis, Asa ^a   Peterson, Brianna L ^a   Couper, Fiona J ^a  

^a Washington State Patrol   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG; (1-PENTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE; INDOLE DERIVATIVE; STREET DRUG; XLR-11;

ADOLESCENT; ADULT; ARTICLE; CAR DRIVING; CLINICAL ARTICLE; EYELID; HUMAN; MALE; SLURRED SPEECH; TREMOR; UNITED STATES; BLOOD; DOSE RESPONSE; FEMALE; PROCEDURES; STANDARDS; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; ALASKA; AUTOMOBILE DRIVING; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDOLES; MALE; STREET DRUGS; SUBSTANCE ABUSE DETECTION; WASHINGTON; YOUNG ADULT;

EID: 84928198953     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku067     Document Type: Article

References (33)

1. Rannazzisi, J.T. (2011) The dangers of synthetic cannabinoids and stimulants. Senate caucus on international narcotics control. US Senate, Washington, DC.
2. Office of National Drug Control Policy/Fact Sheet: Synthetic Marijuana. (2011).
3. US Department of Justice, Drug Enforcement Administration. (2013) Schedule of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Docket DEA-373. Federal Registry, 78, 28735-28739.
4. US Department of Justice, Drug Enforcement Administration. (2014) Schedule of controlled substances: temporary placement of four synthetic cannabinoids into schedule I. Docket DEA-385. Federal Registry, 79, 1776-1780.
5. Washington State Register. (2011) Department of Health WSR 11-22-086. http://apps.leg.wa.gov/documents/laws/wsr/2011/22/11-22-086.htm (accessed March 14, 2014).
6. National Conference of State Legislatures. (2012) Synthetic cannabinoids (AKA K2/Spice) enactments. http://www.ncsl.org/research/civil-and-criminal-justice/synthetic-cannabinoids-enactments.aspx (accessed March 14, 2014).
7. Logan, B.K., Reinhold, L.E., Xu, A., Diamond, F.X. (2012) Identification of synthetic cannabinoids in herbal incense blends in the United States. Journal of Forensic Sciences, 57, 1168-1180.
8. Kronstrand, R., Andersson, M., Eklund, A. (2013) Toxicological findings of synthetic cannabinoids in recreational users. Journal of Analytical Toxicology, 37, 534-541.
9. Centers for Disease Control and Prevention (CDC). (2013) Notes from the field: severe illness associated with reported use of synthetic marijuana-Colorado, August-September 2013. Morbidity and Mortality Weekly Report, 62, 1016-1017.
10. Fantegrossi, W.E., Moran, J.H., Radominska-Pandya, A., Prather, P.L. (2014) Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to D9-THC: mechanism underlying greater toxicity? Life Sciences, 97, 45-54.
11. Spaderna, M., Addy, P.H., D'Souza, D.C. (2013) Spicing things up: synthetic cannabinoids. Psychopharmacology (Berlin), 228, 525-540.
12. Kneisel, S., Teske, J., Autwater, V. (2014) Analysis of synthetic cannabinoids in abstinence control: long drug detection windows in serum and implications for practitioners. Correspondence letter. Drug Testing and Analysis, 6, 135-136.
13. Crews, B.O. (2013) Synthetic cannabinoids: the challenge of testing for designer drugs. Clinical Laboratory News, 39, 8-10.
14. Thornton, S.L., Wood, C., Friesen, M.W., Gerona, R.R. (2013) Synthetic cannabinoid use associated with acute kidney injury. Clinical Toxicology (Phila), 51, 189-190.
15. Wohlfarth, A., Pang, S., Zhu, M., Gandhi, A.S., Scheidweiler, K.B., Liu, H.F. et al. (2013) First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectroscopy. Clinical Chemistry, 59, 1638-1648.
16. Centers for Disease Control and Prevention (CDC). (2012) Acute kidney injury associated with synthetic cannabinoid use-multiple states, 2012. MMWR Morbidity and Mortality Weekly Report, 62, 93-98.
17. Suárez-Pinilla, P., López-Gil, J., Crespo-Facorro, B. (2014) Immune system: a possible nexus between cannabinoids and psychosis. Brain, Behavior and Immunity. pii: S0889-1591(14)00043-9. doi:10.1016/j.bbi.2014.01.018.
18. Forrester, M.B. (2012) Adolescent synthetic cannabinoid exposures reported to Texas poison centers. Pediatric Emergency Care, 28, 985-989.
19. Hermanns-Clausen, M., Kneisel, S., Szabo, B., Auwärter, V. (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108, 534-544.
20. Nacca, N., Vatti, D., Sullivan, R., Sud, P., Su, M., Marraffa, J. (2013) The synthetic cannabinoid withdrawal syndrome. Journal of Addiction Medicine, 7, 296-298.
21. Heath, T.S., Burroughs, Z., Thompson, A.J., Tecklenburg, F.W. (2012) Acute intoxication caused by a synthetic cannabinoid in two adolescents. Journal of Pediatric Pharmacology and Therapeutics, 17, 177-181.
22. Harris, C.R., Brown, A. (2013) Synthetic cannabinoid intoxication: a case series and review. Journal of Emergency Medicine, 44, 360-366.
23. Jinwala, F.N., Gupta, M. (2012) Synthetic cannabis and respiratory depression. Journal of Child and Adolescent Psychopharmacology, 22, 459-462.
24. Favretto, D., Pascali, J.P., Tagliaro, F. (2013) New challenges and innovation in forensic toxicology: focus on the "New Psychoactive Substances". Journal of Chromatography A, 26, 84-95.
25. Thomas, S., Bliss, S., Malik, M. (2012) Suicidal ideation and self-harm following K2 use. Journal of the Oklahoma State Medical Association, 105, 430-433.
26. Fattore, L., Fratta, W. (2011) Beyond THC: the new generation of cannabinoid designer drugs. Frontiers in Behavioral Neuroscience, 5, 60.
27. Washington State Patrol. (2013) Drug recognition and classification training. "The Drug Recognition Expert School" Administrative Guide. http://www.wsp.wa.gov/breathtest/docs/webdms/DRE_ Forms/Manuals/dre7/Instructor%20Guide%20(DRE%207-Day)%20-%20May%202013%20(230MB).pdf (accessed June 17, 2014).
28. Couper, F.J., Logan, B.K. (2004) National Highway Traffic Safety Administration. Drugs and Human Performance Fact Sheets. http://www.nhtsa.gov/people/injury/research/job185drugs/(accessed March 14, 2014).
29. Musshoff, F., Madea, B., Kernbach-Wighton, G., Bicker, W., Kneisel, S., Hutter, M. et al. (2014) Driving under the influence of synthetic cannabinoids ("Spice"): a case series. International Journal of Legal Medicine, 128, 59-64.
30. University of Washington Alcohol and Drug Abuse Institute. (2013) Spice and K2 (Synthetic Marijuana). http://adai.washington.edu/marijuana/factsheets/spice.pdf (accessed March 14, 2014).
31. Presley, B.C., Jansen-Varnum, S.A., Logan, B.K. (2013) Analysis of synthetic cannabinoids in botanical material: a review of analytical methods and findings. Forensic Science Review, 25, 28-46.
32. Johnson, L.A., Johnson, R.L., Portier, R.B. (2013) Current "legal highs". Journal of Emergency Medicine, 44, 1108-1115.
33. Shanks, K.G., Behonick, G.S., Dahn, T., Terrell, A. (2013) Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry. Journal of Analytical Toxicology, 37, 517-525.